Literature DB >> 7429626

Effect of intravenously injected killed pneumococci on leukocytes, complement, and phagocytosis in rabbits.

W P Reed, P Jaffee, E L Albright, R C Williams.   

Abstract

A pneumococcal infection may be lethal in the absence of overwhelming pulmonary involvement, and death may occur even after the organisms have been killed with antibiotics. The mechanism of death is not understood but may be related to circulating pneumococcal products. For investigating the effects of nonviable pneumococci on several host defense mechanisms, rabbits were injected intravenously with 4 X 10(8) colony-forming units of killed sonified type 13 or type 29 pneumococci. Blood was sampled periodically for the next 24 h, and the following were measured: (i) circulating levels of leukocytes; (ii) activity of the classical and alternate complement pathways; and (iii) ability of the serum to opsonize pneumococci for ingestion and killing by polymorphonuclear leukocytes. Saline-injected control rabbits showed no change in any of the functions. Nonimmune rabbits injected with either pneumococcal serotype showed progressive and profound leukopenia, no change or an increase in classical and alternate complement pathway activity, and a profound reduction in the serum-opsonizing capcity for pneumococci of the same serotype as that used in the injection. The opsonizing capacity remained normal for the other serotype. When a previously immunized animal was injected, the opsonizing capacity for the homologous organism remained intact, but leukopenia nervertheless occurred.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429626      PMCID: PMC551233          DOI: 10.1128/iai.29.3.1021-1027.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

2.  Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis.

Authors:  R K Dhingra; R C Williams; W P Reed
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

3.  Pulmonary capillary thrombosis in experimental pneumococcal septicemia.

Authors:  F G Dalldorf; D H Pate; R D Langdell
Journal:  Arch Pathol       Date:  1968-02

4.  Complement components of a haemolytically deficient strain of rabbits.

Authors:  R A Nelson; C E Biro
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

5.  A rapid slide-agglutination method for typing pneumococci by means of specific antibody adsorbed to protein A-containing staphylococci.

Authors:  G Kronvall
Journal:  J Med Microbiol       Date:  1973-05       Impact factor: 2.472

6.  The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule.

Authors:  J A Winkelstein; H S Shin
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

7.  Pneumococcal pneumonia: capsular polysaccharide antigenemia and antibody responses.

Authors:  J D Coonrod; D P Drennan
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

8.  Clinical and bacteriological events in experimental lethal pneumococcal infection.

Authors:  J E Perry; L E Cluff
Journal:  Tex Rep Biol Med       Date:  1966

9.  Complement system in pneumococcal infections.

Authors:  W P Reed; M S Davidson; R C Williams
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

10.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.

Authors:  P R Craddock; J Fehr; K L Brigham; R S Kronenberg; H S Jacob
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

View more
  2 in total

1.  Effect of immunization on the genesis of pneumococcal endocarditis in rabbits.

Authors:  S W Adler; D S Selinger; W P Reed
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

2.  Opsonic requirements for hepatic clearance of pneumococci.

Authors:  W P Reed; E L Albright
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.